Deep learning models predict regulatory variants in pancreatic islets and refine type 2 diabetes association signals
Abstract
Genome-wide association analyses have uncovered multiple genomic regions associated with T2D, but identification of the causal variants at these remains a challenge. There is growing interest in the potential of deep learning models - which predict epigenome features from DNA sequence - to support inference concerning the regulatory effects of disease-associated variants. Here, we evaluate the advantages of training convolutional neural network (CNN) models on a broad set of epigenomic features collected in a single disease-relevant tissue – pancreatic islets in the case of type 2 diabetes (T2D) - as opposed to models trained on multiple human tissues. We report convergence of CNN-based metrics of regulatory function with conventional approaches to variant prioritization – genetic fine-mapping and regulatory annotation enrichment. We demonstrate that CNN-based analyses can refine association signals at T2D-associated loci and provide experimental validation for one such signal. We anticipate that these approaches will become routine in downstream analyses of GWAS.
Data availability
The datasets analysed during the current study are available in the public repositories under accessions listed in STable 1.
-
Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility lociEuropean Genome-Phenome Archive, EGAS00001002592.
-
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature GenesNCBI Gene Expression Omnibus, GSE76268.
-
Duke_DnaseSeq_PanIsletsNCBI Gene Expression Omnibus, GSM816660.
-
UNC_FaireSeq_PanIsletsNCBI Gene Expression Omnibus, GSM864346.
-
DNaseI/FAIRE/ChIP Synthesis from ENCODE/OpenChrom(Duke/UNC/UTA)NCBI Gene Expression Omnibus, GSE40833.
-
BI Human Reference Epigenome Mapping Project: ChIP-Seq in human subjectNCBI Gene Expression Omnibus, GSE19465.
-
UCSF-UBC Human Reference Epigenome Mapping ProjectNCBI Gene Expression Omnibus, GSE16368.
-
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogrammingNCBI Gene Expression Omnibus, GSE50386.
Article and author information
Author details
Funding
Wellcome (099673/Z/12/Z)
- Matthias Thurner
Horizon 2020 Framework Programme (T2D Systems)
- Anna L Gloyn
NIH Clinical Center (U01-DK105535)
- Anna L Gloyn
- Mark I McCarthy
NIH Clinical Center (U01-DK085545)
- Anna L Gloyn
National Institute for Health Research (NF-SI-0617-10090)
- Anna L Gloyn
Wellcome (090532)
- Mark I McCarthy
Wellcome (106130)
- Anna L Gloyn
- Mark I McCarthy
Wellcome (098381)
- Mark I McCarthy
Wellcome (203141)
- Anna L Gloyn
- Mark I McCarthy
Wellcome (212259)
- Mark I McCarthy
Wellcome (095101)
- Anna L Gloyn
Wellcome (200837)
- Anna L Gloyn
Medical Research Council (MR/L020149/1)
- Anna L Gloyn
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Stephen Parker, University of Michigan, United States
Version history
- Received: August 30, 2019
- Accepted: January 27, 2020
- Accepted Manuscript published: January 27, 2020 (version 1)
- Version of Record published: February 7, 2020 (version 2)
Copyright
© 2020, Wesolowska-Andersen et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,056
- Page views
-
- 617
- Downloads
-
- 18
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cancer Biology
- Computational and Systems Biology
Non-invasive early cancer diagnosis remains challenging due to the low sensitivity and specificity of current diagnostic approaches. Exosomes are membrane-bound nanovesicles secreted by all cells that contain DNA, RNA, and proteins that are representative of the parent cells. This property, along with the abundance of exosomes in biological fluids makes them compelling candidates as biomarkers. However, a rapid and flexible exosome-based diagnostic method to distinguish human cancers across cancer types in diverse biological fluids is yet to be defined. Here, we describe a novel machine learning-based computational method to distinguish cancers using a panel of proteins associated with exosomes. Employing datasets of exosome proteins from human cell lines, tissue, plasma, serum, and urine samples from a variety of cancers, we identify Clathrin Heavy Chain (CLTC), Ezrin, (EZR), Talin-1 (TLN1), Adenylyl cyclase-associated protein 1 (CAP1), and Moesin (MSN) as highly abundant universal biomarkers for exosomes and define three panels of pan-cancer exosome proteins that distinguish cancer exosomes from other exosomes and aid in classifying cancer subtypes employing random forest models. All the models using proteins from plasma, serum, or urine-derived exosomes yield AUROC scores higher than 0.91 and demonstrate superior performance compared to Support Vector Machine, K Nearest Neighbor Classifier and Gaussian Naive Bayes. This study provides a reliable protein biomarker signature associated with cancer exosomes with scalable machine learning capability for a sensitive and specific non-invasive method of cancer diagnosis.
-
- Computational and Systems Biology
- Immunology and Inflammation
Intravital microscopy has revolutionized live-cell imaging by allowing the study of spatial–temporal cell dynamics in living animals. However, the complexity of the data generated by this technology has limited the development of effective computational tools to identify and quantify cell processes. Amongst them, apoptosis is a crucial form of regulated cell death involved in tissue homeostasis and host defense. Live-cell imaging enabled the study of apoptosis at the cellular level, enhancing our understanding of its spatial–temporal regulation. However, at present, no computational method can deliver robust detection of apoptosis in microscopy timelapses. To overcome this limitation, we developed ADeS, a deep learning-based apoptosis detection system that employs the principle of activity recognition. We trained ADeS on extensive datasets containing more than 10,000 apoptotic instances collected both in vitro and in vivo, achieving a classification accuracy above 98% and outperforming state-of-the-art solutions. ADeS is the first method capable of detecting the location and duration of multiple apoptotic events in full microscopy timelapses, surpassing human performance in the same task. We demonstrated the effectiveness and robustness of ADeS across various imaging modalities, cell types, and staining techniques. Finally, we employed ADeS to quantify cell survival in vitro and tissue damage in mice, demonstrating its potential application in toxicity assays, treatment evaluation, and inflammatory dynamics. Our findings suggest that ADeS is a valuable tool for the accurate detection and quantification of apoptosis in live-cell imaging and, in particular, intravital microscopy data, providing insights into the complex spatial–temporal regulation of this process.